ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.23X leverage
Alivus Life Sciences live price: ₹925.45. It opened at ₹945 vs previous close ₹945; intraday high/low: ₹947/₹908. The 50 & 200 DMA stand at ₹915.39/₹940.73.
Alivus Life Sciences Performance
- Low
- ₹908
- High
- ₹947
- 52 Week Low
- ₹819
- 52 Week High
- ₹1,225
- Open Price₹945
- Previous Close₹945
- Volume54,611
- 50 DMA₹915.39
- 100 DMA₹919.99
- 200 DMA₹940.73
Investment Returns
- Over 1 Month + 0.61%
- Over 3 Month + 1.61%
- Over 6 Month -0.55%
- Over 1 Year -9.62%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.9
- PEG Ratio
- 0.9
- Market Cap Cr
- 11,359
- P/B Ratio
- 3.6
- Average True Range
- 31.61
- EPS
- 45.82
- Dividend Yield
- 0.5
- MACD Signal
- 3.5
- RSI
- 59.39
- MFI
- 52.75
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹925.45
-19.45
(-2.06%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹922.47
- 50 Day
- ₹915.39
- 100 Day
- ₹919.99
- 200 Day
- ₹940.73
Resistance and Support
936.45
- R3 985.00
- R2 966.00
- R1 955.45
- S1 925.90
- S2 906.90
- S3 896.35
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹925 As on 16 March, 2026 | 16:06
The Market Cap of Alivus Life Sciences is ₹11358.6 Cr As on 16 March, 2026 | 16:06
The P/E ratio of Alivus Life Sciences is 20.9 As on 16 March, 2026 | 16:06
The PB ratio of Alivus Life Sciences is 3.6 As on 16 March, 2026 | 16:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.